- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Perioperative venous thromboembolism prophylaxis: European guidelines
European Society of Anaesthesiology has released European guidelines on Perioperative venous thromboembolism prophylaxis. The Guidelines have been published in the European Journal of Anaesthesiology.
In Perioperative period the patient is not ambulatory and is, therefore, more prone to venous thromboembolism( VTE) In order to prevent venous thromboembolism (VTE), early ambulation, pharmacological thromboprophylaxis using anticoagulants and mechanical thromboprophylaxis by means of graduated compression stockings (GCS) and intermittent pneumatic compression (IPC) have been advocated.
Mechanical thromboprophylaxis or compression therapy reduces the risk of deep venous thrombosis (DVT) but its impact on symptomatic VTE and in particular PE remains unclear and varies in different clinical settings. Intermittent pneumatic compression appears to reduce the risk of DVT by approximately 50% but considerable heterogeneity exists in the choice of device, with most of the included studies combining IPC with GCS. Thus, there is currently no conclusive evidence on the impact of IPC for the prevention of PE.
The guidelines recommend against the use of GCS alone without pharmacological thromboprophylaxis for prevention of VTE in patients at intermediate and high risk. For patients at high risk of VTE with contraindications for pharmacological thromboprophylaxis, we recommend the use of mechanical prophylaxis and suggest the use of IPC over GCS.
Major Recommendations are-
• We recommend an institution-wide protocol for the prevention of VTE that integrates early ambulation, pharmacological thromboprophylaxis with anticoagulants and mechanical thromboprophylaxis (Grade IB).
• We recommend against the routine use of GCS without pharmacological thromboprophylaxis to prevent VTE in patients at intermediate and high risk (Grade IB).
• In patients with contraindications to pharmacological thromboprophylaxis, we recommend the use of mechanical prophylaxis with IPC or GCS (Grade IB) and suggest the use of IPC over GCS (Grade 2B).
• In patients with contraindications to pharmacological thromboprophylaxis who are not at high-risk for VTE, we suggest no prophylaxis over GCS alone (Grade 2C).
• In patients receiving pharmacological thromboprophylaxis who are not at very high risk for VTE, we recommend against the routine use of mechanical thromboprophylaxis with GCS or IPC (Grade IB).
• We suggest combined mechanical and pharmacological prophylaxis in selected patients at very high-risk for VTE (grade 2B). We suggest the use of IPC rather than GCS in selected high-risk patients in addition to pharmacological thromboprophylaxis (Grade 2B).
For further reference log on to :
European Journal of Anaesthesiology (EJA) DOI: 10.1097/EJA.0000000000000726
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751